News about Biotechnology

BELLUS Health Convenes Virtual KOL Meeting to Discuss the State of Chronic Cough Treatment

Bellus a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders, today announced that it will convene a virtual Key Opinion Leader (KOL) meeting to discuss the chronic cough landscape on Wednesday, May 27, 2020 at 9:00 a.m. EDT

Biotechnology | 15/05/2020 | By Darshana |  297

ICMR notifies NIMHANS as mentor institution for RT-PCR test protocol for COVID-19

The National Institute of Mental Health and Neuro Sciences (NIMHANS) has been notified by the Indian Council of Medical Research (ICMR) and the Medical Council of India (MCI) as the mentor institution for RT-PCR (Reverse transcription-polymerase chain reaction) test

Biotechnology | 10/05/2020 | By Darshana |  260

Hydroxychloroquine and Chloroquine Marketto more than Double in 2020 ? TechSci Research

Increase in prevalence of COVID-19 to drive demand for hydroxychloroquine and chloroquine across the globe

Biotechnology | 29/04/2020 | By Darshana |  164

Alembic Pharma gets US FDA approval for Lastacaft ophthalmic solution

Alembic Pharmaceuticals Limited has received tentative approval from the US Food & Drug Administration (FDA) for its abbreviated new drug application (ANDA) alcaftadine ophthalmic solution, 0.25%

Biotechnology | 21/04/2020 | By Darshana |  712

Oncolytics Biotech updates clinical development & operations activities during COVID-19 pandemic

Oncolytics Biotech Inc., currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, provided an update on the potential impact of COVID-19 on the company's clinical and business operations

Biotechnology | 20/04/2020 | By Darshana |  268

FDA Encourages Recovered Patients to Donate Plasma for Development of Blood-Related Therapies

As part of the all-of-America approach to fighting the COVID-19 pandemic, the U.S. Food and Drug Administration has been working with partners across the U.S. government, academia and industry to expedite the development and availability of critical medical products to treat this novel virus

Biotechnology | 19/04/2020 | By Darshana |  251

Abbott Launches Molecular Point-Of-Care Test, ID NOW COVID-19 Tests to Detect Coronavirus in as Little as 5 Minutes

Abbott announced that the US Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19), delivering positive results in as little as five minutes and negative results in 13 minutes

Biotechnology | 30/03/2020 | By Darshana |  844

Mylab Ships First Batch of COVID 19 Test Kits To Government And Private Labs

First batch of Made in India Testing kit for Covid-19 to be shipped today, Government and private labs approved by ICMR to conduct tests. Mylab can ramp-up capacity from 20,000 to 50,000 kits a day if needed

Biotechnology | 27/03/2020 | By Darshana |  571

First Made in India COVID-19 tests kit by Mylab gets commercial approval from the government

Mylab is the first Indian company getting commercial COVID-19 PCR kit approved by CDSCO.Mylab COVID-19 test kits cost nearly one-fourth of the currently procured kits. Mylab uses advanced protocols which can reduces testing time by 65%

Biotechnology | 24/03/2020 | By Darshana |  1175

DST invites proposals for prevention and therapy of COVID-19

The Technology Development Board (TDB), a statutory body under Department of Science and Technology (DST) has invited proposal applications from Indian companies to address protection and home-based therapeutic respiratory intervention for coronavirus (COVID-19) patients.

Biotechnology | 24/03/2020 | By Darshana |  391